Skip to main content
SpringerLink
Log in

Kosteneffektivität einer individualisierten Diabetestherapie

Cost effectiveness of individualized diabetes treatment

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. CDC Diabetes Cost-effectiveness Group (2002) Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287:2542–2551

    Article  Google Scholar 

  2. ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr et al (2011) Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 364:818–828. https://doi.org/10.1056/NEJMoa1006524

    Article  Google Scholar 

  3. Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM (2013) UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia 56:1925–1013

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endokrinologie, Diabetologie und klinische Ernährung, Medizinische Klinik, Kantonsspital Münsterlingen, Spitalcampus 1, 8596, Münsterlingen, Schweiz

    V. Pavlicek

Authors
  1. V. Pavlicek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Pavlicek.

Ethics declarations

Interessenkonflikt

V. Pavlicek gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pavlicek, V. Kosteneffektivität einer individualisierten Diabetestherapie. Diabetologe 14, 180–181 (2018). https://doi.org/10.1007/s11428-018-0326-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-018-0326-y

Search

Navigation